Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion type Assertion NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_head.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion description "[EGFR mutations were identified in 13 (10.5%) of fully evaluated cases (11 in adenocarcinoma and two in NSCLC-NOS) including two novel mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_provenance.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion evidence source_evidence_literature NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_provenance.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion SIO_000772 21949883 NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_provenance.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion wasDerivedFrom befree-2016 NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_provenance.
- NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_assertion wasGeneratedBy ECO_0000203 NP926670.RAsnsQtPig4Xt5eGS4lAZEvSovtQHS_QtQ_AiKIeesEfo130_provenance.